Galatea Bio Inc.

United States - Miami Lakes, Florida

• 28/03/2025
• Unknown
• $25,000,000

We are building the largest longitudinal cohort in the Americas to power precision health at scale for all. Our goal is to improve diagnostic testing and accelerate drug discovery in diverse underserved populations. We are focused on Latin America and our diaspora populations throughout the world including founder populations in the Americas, those who identify as Hispanic/Latino, Black or African American, Asian American, American Indian/Alaska Native, First Nations, and Native Hawaiian/Pacific Islander as well as people who self identify as belonging to two or more of these groups.

Core to our mission is building trust with the communities we serve and long term partnerships with communities, researchers, clinicians, and most of all patients and their families.

This is your biobank and for the benefit of all. If we build it, we can decide how the data are used. And no one is going to do it for us, so let’s roll up our sleeves and “time to build.” Join us!

Este biobanco es tuyo y para todo el continente porque si lo construimos juntos podemos decidir cómo se usan los datos y con que fines. Nadie lo va a hacer por nosotros así que bienvenido a nuestro esfuerzo. Unete!

Related People

Carlos D. BustamanteFounder

United States - Miami-Fort Lauderdale Area

Hi! I’m Carlos. I am a scientist, executive, and academic. I am the founder and CEO of Galatea Bio, a company spun out of my lab at Stanford, where we use genomics and data science to drive precision health at scale for all.

I have lead teams at the interface of genomics, data science, and precision health at Cornell (2002-2009), Stanford (2010-2022), and in the private sector (2021-). Aside from running Bustamante Lab and Galatea Bio, I co-founded the Stanford Center for Computational, Evolutionary, and Human Genomics (2012-2016) and was the inaugural Chair of the Department of Biomedical Data Science at Stanford Medicine (2016-2019). I have taught at U. Miami since 2017 and work with the entrepreneurship and technology groups at Miami Herbert Business School. Since 2021, I've been an advisor to Miami Dade Community College serving on the BioScience Advisory Committee. Since 2019, I have been a Venture Partner at F/Prime Capital where we initially incubated Galatea Bio. I enjoy consulting for companies, investors, and non-profits through my boutique IP and strategy consulting practice, CDB Consulting Group, Inc.

Please reach out and see how we can collaborate and work together!

LinkedIn https://www.linkedin.com/in/carlos-d-bustamante-5007a31a/